HANSOH PHARMA (03692) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Bullish market stimulation boosts Hong Kong healthcare stocks, causing Lai Kai Pharmaceuticals to surge over 18%.
①What bullish news about pharmaceutical stocks has recently been announced in the market? ②How do institutions view the subsequent performance of pharmaceutical stocks?
cls.cnNov 19 22:50 ET
Will the indications of GLP-1 drugs expand to the field of PCOS? The era of three targets is about to arrive? | Industry Observation
①At the GLP-1 Drug Seminar (Chengdu session), participants discussed the global trend of GLP-1 drug research and development. ②Participants mentioned that the indications for GLP-1 drugs in the future may expand to areas such as PCOS and stroke. ③Drugs targeting GLP, GCG, and GIP receptors are beginning to rise.
cls.cnNov 19 08:17 ET
Guosheng Securities: The trend of the domestic innovative drug industry is gradually shifting from license-in to license-out.
Against the backdrop of fierce competition and internal circulation of innovative drug targets in the domestic market, going global is expected to break through the profit ceiling of the domestic market and follow the trend of global innovation.
Zhitong FinanceNov 18 02:00 ET
Are Investors Undervaluing Hansoh Pharmaceutical Group Company Limited (HKG:3692) By 36%?
Simply Wall StNov 12 18:59 ET
The new policy of prepayment of medical insurance fund has been released, and the pharmaceutical sector has ushered in a sharp rise. Experts believe it may be a way for medical institutions to release funding pressure.
On the 11th, the "Notice on Prepayment of Medical Insurance Fund" was issued, requiring the unified and improved basic medical insurance fund prepayment system at the national level. Experts believe that the prepayment system can effectively alleviate the problem of pharmaceutical industry debt, accelerate the turnover of funds for pharmaceutical companies. The medical sector showed a significant upward trend today, with listed companies attributing the rise to investor sentiment.
cls.cnNov 12 02:44 ET
Multiple bullish factors boost pharmaceutical Hong Kong stocks. Institutions say they still face this risk in the short term.
①What are the policy measures to support the field of innovative drugs? ②What unfavorable effects on domestic pharmaceutical stocks might Trump's election bring about?
cls.cnNov 11 21:59 ET

Comments

Bull X Bear

Oct 3 02:14

What would you buy in your Hong Kong portfolio?

Banks: $ABC (01288.HK)$ $BANK OF CHINA (03988.HK)$
Securities & Brokerage: $HTSC (06886.HK)$ $CMSC (06099.HK)$
Gaming Software: $NTES-S (09999.HK)$ $XD INC (02400.HK)$ $NETDRAGON (00777.HK)$
Digital Solutions: $TENCENT (00700.HK)$ $TRAVELSKY TECH (00696.HK)$ $CHINASOFT INT'L (00354.HK)$
Online Retailer: $BABA-W (09988.HK)$ $MEITUAN-W (03690.HK)$ $JD-SW (09618.HK)$
Insurer: $PING AN (02318.HK)$ $AIA (01299.HK)$ $CHINA LIFE (02628.HK)$
Telecommunication: $CHINA MOBILE (00941.HK)$ $CHINA TELECOM (00728.HK)$
...

Officials say the real estate market is bottoming out. What’s your view on China's property market?

15

7

Trader’s Edge

Sep 25 06:05

Columns Chinese Market Blitzkrieg: Is it any different this time?

Background
Chinese indices have been ripping higher the past 2 days. To put things in perspective, this is only the 2nd time in 2024 (and since Jan 2023) where we see the onshore indices post a bigger rally than the HSI.
1st Time (February 2024):CSI 300 was up by+10% while the HSI was up by only +7.7%
2nd Time (September 2024):CSI 300 up by+6.3% while the HSI was up by only +4.9%
So... what led to this sudden outperformance?
On 24th Septem...

+2

Officials say the real estate market is bottoming out. What’s your view on China's property market?

42

4

Trader’s Edge

Sep 8 21:56

Columns Stocks we're watching this week - KMB, MET and more

Stocks to Watch
Kimberly-Clark Corporation (KMB US) $Kimberly-Clark (KMB.US)$
Daily Chart -[BULLISH ↗ **]KMB is holding above mid-term ascending trendline support and hasbeen making a series of higher highs and higher lows. As long as price is holding above 142 support, a further push higher towards 155.70 resistance is expected. Technical indicators are advocating for a bullish scenario.
Alternatively: A daily candlestick closingbelow 142 suppor...

+3

20

Moomoo AI

Mar 4 16:46

Hansoh Pharmaceutical Group's high P/E ratio may be due to expected earnings recovery. However, with lower than market growth forecast, the high P/E ratio and positive investor sentiment may not be sustainable. Current trading prices may not be reasonable without significant improvement.

Optimistic Investors Push Hansoh Pharmaceutical Group Company Limited (HKG:3692) Shares Up 28% But Growth Is Lacking

1

Moomoo AI

Feb 11 22:53

Hansoh Pharmaceutical Group's strong financials and moderate growth over the past five years, along with its high rate of profit reinvestment, could potentially boost its stock value in the long-term. Analysts anticipate future earnings momentum.

Hansoh Pharmaceutical Group Company Limited (HKG:3692) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

03692 HANSOH PHARMA

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target